Skip to Main Content

Advertisement

Skip Nav Destination

Abstract CN07-01: A phase IIa randomized, double-blind trial of erlotinib in inhibiting EGF receptor signaling in aberrant crypt foci of the colon

Cancer Prev Res (Phila) (2013) 6 (11_Supplement): CN07-01.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal